Status:
COMPLETED
Feasibility of a Multi Component Intervention in Patients With Severe Dyspnea and Obesity
Lead Sponsor:
Mayo Clinic
Conditions:
COPD
Emphysema
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Researchers are trying to test the effectiveness and feasibility of a multicomponent lifestyle intervention to support weight loss decreases dyspnea in obese people with chronic lung disease and clini...
Detailed Description
Patient will be randomized to a 12-week intervention that uses the Weight watchers lifestyle program online, a Garmin Fitness Tracker, blue tooth scale and receive health coaching vs a wait-list contr...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- Age ≥ 18 years.
- BMI \>=35
- Dyspnea MRC class II or greater
- Diagnosis of lung disease
- Signed informed consent
- Exclusion Criteria
- BMI \<35
- Pregnancy
- Recent respiratory illness (within the last 6 weeks)
- Recent exacerbation of chronic lung disease (within the last 6 weeks)
- Already participating in a structured diet and/or exercise program
- Medical contraindication to weight loss (cancer)
- Medical contraindication to unsupervised exercise (unstable angina)
Exclusion
Key Trial Info
Start Date :
December 19 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2022
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT03836547
Start Date
December 19 2019
End Date
September 30 2022
Last Update
November 2 2022
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259
2
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224
3
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905